Cornea Specialist, Clinician-Scientist, Fuchs dystrophy & corneal regeneration researcher @Sunnybrook l @UofTDOVS l @UofTmedicine | @LMP_UofT | Opinions my own
I’m proud to share our publication in @SciReports demonstrating how the most common mutation in #fuchsdystrophy in TCF4 can promote increased corneal endothelial cellular migration by altering microtubules.
@FB_Canada@Sunnybrook@UofTDOVS
https://t.co/0kTDxhI7HL
Excited to share the first paper from my lab. We validated Canadian eye bank prepared preloaded DMEK tissues, and have now started offering this to Canadian surgeons and their patients.
@Sunnybrook@UofTDOVS
https://t.co/MgvxAf11TK
Proud to be part of this landmark paper using patients’ own ex-vivo expanded stem cells to treat limbal stem cell deficiency @MassEyeAndEar@Sunnybrook@UofTDOVS#stemcells#cornea Cultivated autologous limbal epithelial cell (CALEC) Science Advances https://t.co/hT7ph1jFO6
Med student Stephanie Jarvi presenting our work on developing EVs as a therapeutic for corneal transplant rejection @UofTDOVS research day. @UofT_LMP@Sunnybrook@HonSing
A research team led by scientist @CarolSchuurmans has been awarded a $24 million New Frontiers grant to develop a game-changing approach to combat incurable neurological disorders, like Alzheimer’s, stroke and epilepsy.
Learn more about the project: https://t.co/e9gsuFYnnN
Corneal crosslinking is an important treatment for #keratoconus. In this study we look at subjective and objective measurements of corneal haze and it’s effect on vision in 483 eyes. #eye#vision
As one of the most severe forms of ocular trauma, open-globe injury (OGI) causes significant vision loss. This video-based educational curriculum is a comprehensive reference for OGI repair. https://t.co/I1JIOB5aRQ
Honoured to be awarded with the High Impact Research Grant to study the therapeutic potential of placental-derived molecules for corneal transplant rejection and injuries. @restoresight@HonSing@Sunnybrook@UofTDOVS @LMP_UofT @UofT_DoM
Excited to share our latest paper (long in the making!) in which we identify BCOR as a novel corepressor for CRX/OTX2 in the retina and show that mutations in BCOR cause retinal degenerations in humans. See thread below if you want to know more.
https://t.co/HceYmhgBw9
Congrats to @LMP_UofT SURE summer student Keya Patel and @jjudyyan on their 1st prize poster on #Fuchsdystrophy and #EMT! #OngToneLab See all the prize winners 👉 https://t.co/lKEtdjiFlv
FBC-funded researcher Dr. Ong Tone swapped his white coat for a cycling jersey at this year's Cycle for Sight event in Toronto. He & his team helped raise $14,500 for vision research.
Learn more about his research & what inspires him: https://t.co/OzCdHAl3hQ
#CycleForSight
We had a great time at @FB_Canada Cycle for Sight. We want to demonstrate to our kids the importance of living an active lifestyle, contributing back to the community and supporting vision research. #eye#fuchsdystrophy https://t.co/NS28KvKKtg